Evidence map›Paper›PMID 29695233›Full record

ArticleLipids in health and disease2018

Apigetrin inhibits adipogenesis in 3T3-L1 cells by downregulating PPARγ and CEBP-α.

Fatma Hadrich, Sami Sayadi

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Polyphenol-Rich Extract ofPlants (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. The Effect ofPlants (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Iranian journal of basic medical sciences · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. IL-25 directly modulates adipocyte function and inflammation through the regulation of adiponectin.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Fatma HadrichEnvironmental Bioprocesses Laboratory, AUF Regional Excellence Pole (AUF-PER-LBP), Sfax Biotechnology Center, P.O. Box 1177, 3038, Sfax, Tunisia. fati_hadrich@yahoo.fr.ORCID http://orcid.org/0000-0002-2788-7874
Sami SayadiEnvironmental Bioprocesses Laboratory, AUF Regional Excellence Pole (AUF-PER-LBP), Sfax Biotechnology Center, P.O. Box 1177, 3038, Sfax, Tunisia. sami.sayadi@cbs.rnrt.tn.
Centre of Biotechnology of Sfax · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundApigetrin, a flavonoid found in many plant leaves and seeds, has been known to possess antimutagenic, anti-cancer, antioxidant and anti-inflammatory properties. Here, we are investigating the effect of the apigetrin on adipocytes differentiation in 3T3-L1 adipocytes, and elucidating the mechanism of its action.

methodsLipids accumulation was measured by Oil Red O staining and cell cycle was analyzed by flow cytometry. The antioxidant effect of apigetrin was evaluated against hydrogen peroxide. The expression of various genes, involved in adipogenesis and inflammation, was studied by real-time PCR.

resultsOur results showed that apigterin treatment inhibited significantly lipid accumulation without effect on cell viability at 100 μM, and it exerted the anti-adipogenic effect during the early stages of differentiation. Flow cytometry analysis showed that apigenin-7-O-glucoside (Ap7G) inhibited cell proliferation during mitotic clonal expansion and caused cell cycle delay. Quantitative PCR analysis revealed that the mRNA levels of C/EBP-α, PPAR-γ, SREBP-1c and FAS were suppressed after apigetrin treatment at 100 μM. Moreover, the mRNA level of pro-inflammatory genes (TNF-α and IL-6) were suppressed after apigterin treatment, at high concentration preadipocyte cells.

conclusionTaken together, these results indicated that apigenin-7-O-glucoside inhibits adipogenesis of 3T3-L1 preadipocytes at early stage of adipogenesis.

Indexed as

3T3-L1 CellsAdipocytesAdipogenesisAnimalsAnti-Inflammatory AgentsAntioxidantsApigeninCCAAT-Enhancer-Binding ProteinsCell Differentiationfas ReceptorGene Expression RegulationInterleukin-6Interleukin-6 InhibitorsMicePPAR gammaRNA, MessengerAnti-Inflammatory AgentsAntioxidantsApigeninapigetrinCCAAT-Enhancer-Binding ProteinsCEBPA protein, mouseFas protein, mousefas ReceptorInterleukin-6Interleukin-6 Inhibitorsinterleukin-6, mousePPAR gammaRNA, MessengerSrebf1 protein, mouseSterol Regulatory Element Binding Protein 1Tumor Necrosis Factor-alphaAdipogenesisApigetrinCell cycleIL-6ROSTNF-α

Identifiers

PMID29695233
PMCPMC5922308
OpenAlexW2800411605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.